In the CHARM trial, increases in alanine aminotransferase (ALT) and total bilirubin (TB), and a decrease in albumin (Alb) were noted in 3%, 13%, and 18% of 2,679 patients with chronic heart failure, respectively [2]. This evidence concerns the gene ALB and congestive heart failure.